CD34+ stem cell top‐ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies
- 16 October 2006
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 135 (4) , 533-537
Abstract
Summary: Haematopoietic stem cell transplantation can be limited by ineffective haematopoiesis and poor immune recovery. A CD34+ cell infusion without conditioning has the potential to improve stem cell function with limited toxicity. Eighteen patients with congenital immunodeficiencies received CD34+ boosts for various defects. When given 1 year after the original graft; only minimal changes in immune function or chimaerism were noted. Unconditioned stem cell boosts have limited toxicity but should be given early after the original graft to be effective.Keywords
This publication has 9 references indexed in Scilit:
- Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiencyBlood, 2006
- Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiencyBone Marrow Transplantation, 2005
- Severe cutaneous papillomavirus disease after haematopoietic stem‐cell transplantation in patients with severe combined immunodeficiencyBritish Journal of Haematology, 2004
- Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common γc cytokine receptor subunit or JAK-3 deficiencyThe Lancet, 2004
- Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99The Lancet, 2003
- Nonmyeloablative stem cell transplantation for congenital immunodeficienciesBlood, 2000
- Long-Term Chimerism and B-Cell Function After Bone Marrow Transplantation in Patients With Severe Combined Immunodeficiency With B Cells: A Single-Center Study of 22 PatientsBlood, 1999
- Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantationBone Marrow Transplantation, 1998
- European experience of bone-marrow transplantation for severe combined immunodeficiencyThe Lancet, 1990